Inventory increased 105.1%
Inventory changed +105.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +105.1% from the comparable as-filed period.
Net income changed -33.7% from the comparable as-filed period.
Operating income changed +25.3% from the comparable as-filed period.
Operating margin changed +196630 basis points from the comparable as-filed period.
Research & development changed +66.8% from the comparable as-filed period.
Revenue changed +1775.4% from the comparable as-filed period.
Selling, general & administrative changed +32.6% from the comparable as-filed period.
Cash & equivalents changed -17.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.